Kamalakannan Palanichamy PhD

Kamalakannan Palanichamy, PhD is an Associate Professor at Ohio State University. He has identified predictive and prognostic markers, elucidated the underlying mechanisms, and validated them using clinically relevant models. His lab group is also working to identify and eradicate cancer stem cells within the bulk of tumors using pre-clinical models and patient-derived cancer stem cells. His recent work identified antigens encoding this sub-population of cells expressing iPSC genes with differentiation plasticity, thus showing that the treatment-resistant tumor-initiating cells can be inhibited by using growth factors.

Kamalakannan has utilized tools from each aspect of my unique background in biology, biochemistry, bioinformatics, crystallography, drug design, and oncology for more than a decade. I have also co-authored more than 40 articles appearing in such respected journals as Cancer Research, Clinical Cancer Research, Neuro-Oncology, Journal of Neuro-Oncology, FEBS, and Journal of Inorganic Biochemistry.